angiotensin ii, des-phe(8)- has been researched along with Alloxan Diabetes in 48 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (18.75) | 29.6817 |
| 2010's | 31 (64.58) | 24.3611 |
| 2020's | 8 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Aimbire, F; Aragão, DS; Bertoncello, N; Casarini, DE; Cunha, TS; de Alcantara Santos, R; de Paula Vieira, R; Guzzoni, V; Schor, N; Silva, KAS | 1 |
| Baranowska, I; Dobrowolski, L; Kompanowska-Jezierska, E; Kuczeriszka, M; Sitek, JD; Walkowska, A | 1 |
| Hao, H; Hao, Y; Li, C; Xu, Y; Zhang, F | 1 |
| He, J; Li, X; Liu, J; Peng, L; Song, G; Wang, X | 1 |
| Nakagawasai, O; Nemoto, W; Takahashi, K; Tan-No, K; Yamagata, R | 1 |
| Jiang, Y; Ren, Y; Sheng, S; Wu, D; Xie, W; Yang, S; Zhang, H | 1 |
| Geng, L; He, J; Li, J; Liu, Y; Wang, X; Xu, T; Yang, J; Zhu, R | 1 |
| Gaikwad, AB; Sharma, N | 1 |
| Chan, JSD; Chenier, I; Filep, JG; Ghosh, A; Ingelfinger, JR; Lo, CS; Scholey, JW; Zhang, SL; Zhao, S | 1 |
| Furukawa, T; Nakagawasai, O; Nemoto, W; Ogata, Y; Shimoyama, S; Tan-No, K; Ueno, S; Yamagata, R | 1 |
| Papinska, AM; Rodgers, KE | 1 |
| Franklin, R; Kuipers, A; Moll, GN; Wagner, E | 1 |
| Ding, W; Gan, L; Gao, L; He, H; Li, X; Li, Y; Liu, J; Ou, S; Wang, M; Wu, W | 1 |
| Fasching, A; Palm, F; Persson, P | 1 |
| Akhtar, S; Benter, IF; El-Hashim, AZ; Kilarkaje, N; Makki, B; Yousif, MH | 1 |
| Gong, X; Li, G; Li, Y; Song, Y; Yuan, L | 1 |
| Abo Alrob, O; Altamimi, T; Basu, R; Desaulniers, J; Kassiri, Z; Lopaschuk, GD; Mori, J; Oudit, GY; Patel, VB; Wagg, CS | 1 |
| de Oliveira, AM; Gomes, MS; Pernomian, L; Restini, CB | 1 |
| Jarajapu, YP; Pawar, R; Singh, N; Vasam, G | 1 |
| Bai, L; Chen, ZQ; Guo, Q; Jia, R; Ma, EW; Ma, Y; Xu, J; Zhang, JH | 1 |
| Guo, T; Hao, P; Kong, J; Li, D; Meng, X; Yang, J; Zhang, C; Zhang, K; Zhang, M; Zhang, Y | 1 |
| Akhtar, S; Benter, IF; El-Hashim, AZ; Makki, B; Yousif, MH | 1 |
| Fan, X; Fan, Y; He, J; Li, X; Wang, L; Wang, W; Wu, H; Yang, H; Yang, Z | 1 |
| Chen, YG; Hao, PP; Yang, JM; Zhang, C; Zhang, K; Zhang, MX; Zhang, Y | 1 |
| Luo, H; Xiao, Q; Zhang, D; Zhao, K | 1 |
| Aragão, DS; Arita, DY; Bertoncello, N; Casarini, DE; Cunha, TS; Dantas, PS; Mattar-Rosa, R; Moreira, RP; Santos, R; Watanabe, IK; Yokota, R | 1 |
| Akhtar, S; Attur, S; Benter, IF; Chandrasekhar, B; Dhaunsi, GS; Yousif, MH | 1 |
| Bernardi, S; Bossi, F; Bramante, A; Candido, R; Carretta, R; De Nardo, D; Fabris, B; Fischetti, F | 1 |
| Bartelmez, SH; Cassis, LA; Jarajapu, YP; Joshi, S; Thatcher, SE; Vasam, G | 1 |
| Batlle, D; David, NV; Fogo, A; Kanwar, Y; Khattab, AM; Martin, A; Osborn, M; Wysocki, J; Ye, M | 1 |
| Gu, J; Li, H; Liu, X; Lu, Y; Ren, Z; Wang, X; Zhang, L | 1 |
| Chen, JL; Pu, D; Sun, Y; Xiao, Q; Zhang, DL; Zhao, KX; Zhao, YX | 1 |
| Akhtar, S; Benter, IF; Dhaunsi, GS; Makki, B; Yousif, M | 1 |
| He, M; Huang, Y; Lu, LM; Shao, Y; Yao, T; Zhou, L | 1 |
| Al-Maghrebi, M; Benter, IF; Diz, DI | 1 |
| Akhtar, S; Benter, IF; Chappell, MC; Dhaunsi, GS; Diz, DI; Yousif, MH | 1 |
| Kim, SH; Oh, YB; Park, BH; Shah, A; Shan, G; Song, CH | 1 |
| Chen, GR; Chen, SP; Ni, LS; Zheng, JC; Zhou, L | 1 |
| Sharma, PL; Singh, K; Singh, T | 1 |
| Almeida, I; Brosnihan, KB; Chappell, MC; Gilliam-Davis, S; Lindsey, SH; Yamaleyeva, LM | 1 |
| Akhtar, S; Benter, IF; Dhaunsi, GS; Makki, BM; Qabazard, BA; Yousif, MH | 1 |
| Abu-Ghefreh, AA; Akhtar, S; Al-Banaw, AG; Benter, IF; George, P; Renno, WM | 1 |
| Igić, R; Jackman, HL; Mahmood, A; Teplitz, L | 1 |
| Al-Maghrebi, M; Benter, IF; Cojocel, C; Diz, DI; Yousif, MH | 1 |
| Achike, FI; Dharmani, M; Mustafa, MR; Sim, MK | 1 |
| Casarini, DE; Irigoyen, MC; Ronchi, FA | 1 |
| Benter, IF; Kehinde, EO; Yousif, MH | 1 |
| Benter, IF; Chappell, MC; Dhaunsi, GS; Diz, DI; Kaur, J; Yousif, MH | 1 |
48 other study(ies) available for angiotensin ii, des-phe(8)- and Alloxan Diabetes
| Article | Year |
|---|---|
Resistance exercise shifts the balance of renin-angiotensin system toward ACE2/Ang 1-7 axis and reduces inflammation in the kidney of diabetic rats.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Kidney; Male; Nephritis; Peptide Fragments; Rats; Rats, Wistar; Renin-Angiotensin System; Resistance Training | 2021 |
Role of Ang1-7 in renal haemodynamics and excretion in streptozotocin diabetic rats.
Topics: Acetylcholine; Angiotensin I; Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diuresis; Drinking; Kidney; Nitric Oxide; Norepinephrine; Peptide Fragments; Random Allocation; Rats; Rats, Sprague-Dawley; Sympathomimetics; Vasodilator Agents | 2022 |
Angiotensin-(1-7) improves diabetes mellitus-induced erectile dysfunction in rats by regulating nitric oxide synthase levels.
Topics: Angiotensin I; Animals; Calcium; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Erectile Dysfunction; Humans; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Peptide Fragments; Proto-Oncogene Proteins c-akt; Rats | 2022 |
Angiotensin(1-7) Improves Islet Function in Diabetes Through Reducing JNK/Caspase-3 Signaling.
Topics: Angiotensin I; Animals; Apoptosis; Blood Glucose; Caspase 3; Diabetes Mellitus, Experimental; Insulin; Male; Peptide Fragments; Rats; Rats, Wistar | 2022 |
Downregulation of spinal angiotensin converting enzyme 2 is involved in neuropathic pain associated with type 2 diabetes mellitus in mice.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Down-Regulation; Male; Mice; Mice, Knockout; Mice, Obese; Mice, Transgenic; Neuralgia; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Peptidyl-Dipeptidase A; Spinal Cord | 2020 |
OIP5-AS1 Attenuates Microangiopathy in Diabetic Mouse by Regulating miR-200b/ACE2.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Caspase 3; Cognition; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Gene Knockdown Techniques; Hippocampus; Maze Learning; Mice; Mice, Knockout; MicroRNAs; Peptide Fragments; Peptidyl-Dipeptidase A; Platelet Endothelial Cell Adhesion Molecule-1; RNA, Long Noncoding | 2020 |
Angiotensin-(1-7) Improves Islet Function in a Rat Model of Streptozotocin- Induced Diabetes Mellitus by Up-Regulating the Expression of Pdx1/Glut2.
Topics: Angiotensin I; Animals; Diabetes Mellitus, Experimental; Glucose Transporter Type 2; Homeodomain Proteins; Insulin-Secreting Cells; Islets of Langerhans; Male; Peptide Fragments; Rats; Rats, Wistar; Streptozocin; Trans-Activators; Up-Regulation | 2021 |
Ameliorative effect of AT2R and ACE2 activation on ischemic renal injury associated cardiac and hepatic dysfunction.
Topics: Acute Kidney Injury; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diminazene; Imidazoles; Ischemia; Kidney; Liver; Male; Myocardium; Oxidative Stress; Peptide Fragments; Peroxidase; Rats, Wistar; Receptor, Angiotensin, Type 2; Sulfonamides; Thiophenes | 2020 |
Nrf2 Deficiency Upregulates Intrarenal Angiotensin-Converting Enzyme-2 and Angiotensin 1-7 Receptor Expression and Attenuates Hypertension and Nephropathy in Diabetic Mice.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation, Enzymologic; Hypertension; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; NF-E2-Related Factor 2; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Up-Regulation | 2018 |
Anti-hypersensitive effect of angiotensin (1-7) on streptozotocin-induced diabetic neuropathic pain in mice.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Hyperesthesia; Male; Mice; Neuralgia; p38 Mitogen-Activated Protein Kinases; Pain Perception; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Spinal Cord; Vasodilator Agents | 2019 |
Long-Term Administration of Angiotensin (1-7) to
Topics: Angiotensin I; Animals; Diabetes Mellitus, Experimental; Gene Expression Regulation, Enzymologic; Kidney; Kidney Glomerulus; Male; Mice, Inbred C57BL; NADPH Oxidases; Nitric Oxide Synthase Type III; Oxidative Stress; Peptide Fragments; Phosphorylation; Shear Strength; Tyrosine | 2018 |
Efficacy of lanthionine-stabilized angiotensin-(1-7) in type I and type II diabetes mouse models.
Topics: Alanine; Angiotensin I; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Insulin; Mice; Mice, Inbred C57BL; Peptide Fragments; Streptozocin; Sulfides; Treatment Outcome | 2019 |
[Aliskiren inhibits angiotensin II/angiotensin 1-7(Ang II/Ang1-7) signal pathway in rats with diabetic nephropathy].
Topics: Amides; Angiotensin I; Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fumarates; Male; Peptide Fragments; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction | 2018 |
Acute intrarenal angiotensin (1-7) infusion decreases diabetes-induced glomerular hyperfiltration but increases kidney oxygen consumption in the rat.
Topics: Angiotensin I; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; Male; Oxygen Consumption; Peptide Fragments; Rats; Rats, Sprague-Dawley | 2019 |
Role of angiotensin II and angiotensin-(1-7) in diabetes-induced oxidative DNA damage in the corpus cavernosum.
Topics: Angiotensin I; Angiotensin II; Animals; Diabetes Mellitus, Experimental; DNA Damage; Male; Oxidative Stress; Penis; Peptide Fragments; Proto-Oncogene Mas; Random Allocation; Rats; Rats, Wistar; Signal Transduction | 2013 |
Ang(1-7) treatment attenuates β-cell dysfunction by improving pancreatic microcirculation in a rat model of Type 2 diabetes.
Topics: Angiotensin I; Angiotensin II; Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Insulin; Insulin Secretion; Islets of Langerhans; Male; Microcirculation; Nitric Oxide; Nitric Oxide Synthase Type III; Pancreas; Peptide Fragments; Rats; Rats, Wistar | 2013 |
Angiotensin 1-7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db/db mice by reducing lipotoxicity and inflammation.
Topics: Angiotensin I; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Diastole; Echocardiography, Doppler; Follow-Up Studies; Inflammation; Insulin Resistance; Lipids; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Function; Ventricular Pressure | 2014 |
MAS-mediated antioxidant effects restore the functionality of angiotensin converting enzyme 2-angiotensin-(1-7)-MAS axis in diabetic rat carotid.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Antioxidants; Blood Flow Velocity; Carotid Arteries; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Hydrogen Peroxide; Male; NADPH Oxidases; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled | 2014 |
Angiotensin-(1-7) reverses angiogenic dysfunction in corpus cavernosum by acting on the microvasculature and bone marrow-derived cells in diabetes.
Topics: Angiotensin I; Animals; Bone Marrow Cells; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Flow Cytometry; Male; Mice; Mice, Inbred C57BL; Microvessels; Neovascularization, Pathologic; Penis; Peptide Fragments; Proto-Oncogene Mas; Real-Time Polymerase Chain Reaction; Vascular Endothelial Growth Factor A | 2014 |
[Effect of Chinese herbs for stasis removing and collaterals dredging upon angiotensin-converting enzyme 2-angiotensin-(1-7)-mas axis in the renal cortex of diabetic nephropathy rats].
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drugs, Chinese Herbal; Kidney Cortex; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled | 2014 |
Angiotensin(1-7) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockade.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Proliferation; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Male; Mesangial Cells; Oxidative Stress; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Valsartan; Vascular Endothelial Growth Factor A | 2015 |
Chronic treatment with Ang-(1-7) reverses abnormal reactivity in the corpus cavernosum and normalizes diabetes-induced changes in the protein levels of ACE, ACE2, ROCK1, ROCK2 and omega-hydroxylase in a rat model of type 1 diabetes.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood Glucose; Body Weight; Cytochrome P-450 CYP4A; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Erectile Dysfunction; Male; Penis; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; rho-Associated Kinases; Streptozocin | 2014 |
Regulation of insulin sensitivity, insulin production, and pancreatic β cell survival by angiotensin-(1-7) in a rat model of streptozotocin-induced diabetes mellitus.
Topics: Angiotensin I; Animals; Apoptosis Regulatory Proteins; Cell Survival; Diabetes Mellitus, Experimental; Disease Models, Animal; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Peptide Fragments; Rats; Rats, Wistar | 2015 |
Angiotensin-(1-7) treatment mitigates right ventricular fibrosis as a distinctive feature of diabetic cardiomyopathy.
Topics: Angiotensin I; Animals; Blood Glucose; Cells, Cultured; Coculture Techniques; Collagen; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Fibrosis; Heart Ventricles; Lipids; Male; Oxidative Stress; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Wistar; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Signal Transduction; Time Factors; Transforming Growth Factor beta1; Ventricular Dysfunction, Right; Ventricular Function, Right; Ventricular Remodeling | 2015 |
[Effects of angiotensin-(1-7) on hippocampal expressions of GFAP and GDNF and cognitive function in rats with diabetes mellitus].
Topics: Angiotensin I; Animals; Astrocytes; Caspase 3; Cognition; Cognition Disorders; Diabetes Mellitus, Experimental; Glial Cell Line-Derived Neurotrophic Factor; Glial Fibrillary Acidic Protein; Hippocampus; Male; Memory; Neurons; Peptide Fragments; Rats; Rats, Sprague-Dawley; Streptozocin | 2015 |
Diabetic Nephropathy Induced by Increased Ace Gene Dosage Is Associated with High Renal Levels of Angiotensin (1-7) and Bradykinin.
Topics: Angiotensin I; Animals; Blood Glucose; Body Weight; Bradykinin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Dosage; Gene Expression Regulation; Genetic Predisposition to Disease; Genotype; Kidney; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Spectrometry, Fluorescence | 2015 |
Transactivation of ErbB Family of Receptor Tyrosine Kinases Is Inhibited by Angiotensin-(1-7) via Its Mas Receptor.
Topics: Angiotensin I; Animals; Blotting, Western; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; ErbB Receptors; Gene Expression Regulation; Glucose; Male; Muscle, Smooth, Vascular; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Transcriptional Activation; Vasodilator Agents | 2015 |
Angiotensin 1-7 significantly reduces diabetes-induced leukocyte recruitment both in vivo and in vitro.
Topics: Angiotensin I; Animals; Cell Adhesion Molecules; Cell Movement; Cells, Cultured; Diabetes Mellitus, Experimental; Endothelium, Vascular; Gene Expression Regulation; Immunohistochemistry; Leukocyte Rolling; Leukocytes; Male; Peptide Fragments; Rats; Real-Time Polymerase Chain Reaction; RNA | 2016 |
Reversal of Bone Marrow Mobilopathy and Enhanced Vascular Repair by Angiotensin-(1-7) in Diabetes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin I; Animals; Blood Vessels; Bone Marrow; Bone Marrow Cells; Cell Lineage; Cell Movement; Chemokine CXCL12; Diabetes Mellitus, Experimental; Ischemia; Male; Membrane Proteins; Mice; Neovascularization, Physiologic; Peptide Fragments; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Recovery of Function; Regeneration; rho-Associated Kinases; Stem Cells; Vascular Endothelial Growth Factor A; Vasodilator Agents | 2017 |
Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy.
Topics: Albuminuria; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Autoantigens; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Kidney; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Peptidyl-Dipeptidase A; Recombinant Proteins; Time Factors | 2017 |
Effects of Diabetic Hyperglycemia on Central Ang-(1-7)-Mas-R-nNOS Pathways in Spontaneously Hypertensive Rats.
Topics: Angiotensin I; Animals; Blood Pressure; Brain; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Dinoprost; Heart Rate; Hyperglycemia; Natriuretic Peptide, Brain; Nitric Oxide Synthase Type I; Oxidative Stress; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, G-Protein-Coupled; Signal Transduction; Spin Labels; Systole | 2016 |
Angiotensin-(1-7) administration attenuates Alzheimer's disease-like neuropathology in rats with streptozotocin-induced diabetes via Mas receptor activation.
Topics: Alzheimer Disease; Angiotensin I; Animals; Diabetes Mellitus, Experimental; Hippocampus; Male; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Streptozocin; Synapses; tau Proteins | 2017 |
Angiotensin-(1-7) Downregulates Diabetes-Induced cGMP Phosphodiesterase Activation in Rat Corpus Cavernosum.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Angiotensin I; Animals; Cyclic GMP; Diabetes Mellitus, Experimental; Down-Regulation; Erectile Dysfunction; Gene Expression Regulation, Enzymologic; Male; Nitrites; p38 Mitogen-Activated Protein Kinases; Penis; Peptide Fragments; Rats; Rats, Wistar; Risk Factors | 2017 |
Chronic angiotensin (1-7) injection accelerates STZ-induced diabetic renal injury.
Topics: Angiotensin I; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; DNA, Complementary; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA | 2008 |
Endogenous angiotensin-(1-7) reduces cardiac ischemia-induced dysfunction in diabetic hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Captopril; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Heart; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Myocardium; NF-kappa B; Nuclear Proteins; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; RNA, Messenger; Signal Transduction | 2009 |
Angiotensin-(1-7) prevents diabetes-induced attenuation in PPAR-gamma and catalase activities.
Topics: Acetophenones; Angiotensin I; Animals; Antihypertensive Agents; Antioxidants; Blood Glucose; Blood Pressure; Catalase; Diabetes Mellitus, Experimental; Endothelin-1; Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating); Hyperglycemia; Hypertension; Kidney; Male; NADPH Oxidases; Peptide Fragments; PPAR gamma; Proteinuria; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Artery | 2010 |
Angiotensin-(1-7) attenuates hyposmolarity-induced ANP secretion via the Na+-K+ pump.
Topics: Angiotensin I; Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic GMP; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Heart; Heart Atria; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Nitric Oxide; Osmolar Concentration; Peptide Fragments; Perfusion; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase; Stress, Physiological; Time Factors | 2010 |
[The effect of angiotensin-(1-7) on the mRNA expression of PDGF and TGF-beta1 in the kidney of diabetic rats].
Topics: Angiotensin I; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; Male; Peptide Fragments; Platelet-Derived Growth Factor; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta1 | 2008 |
Beneficial effects of angiotensin (1-7) in diabetic rats with cardiomyopathy.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Glucose; Collagen; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Dyslipidemias; Fibrosis; Heart Ventricles; Hypertrophy, Left Ventricular; Lipids; Nitrates; Nitrites; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2011 |
Differential regulation of circulating and renal ACE2 and ACE in hypertensive mRen2.Lewis rats with early-onset diabetes.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biomarkers; Blood Pressure; Blotting, Western; C-Reactive Protein; Chromatography, High Pressure Liquid; Collagen; Diabetes Mellitus, Experimental; Female; Hypertension; Immunohistochemistry; Kidney; Male; Muscle Contraction; Muscle, Smooth, Vascular; Neprilysin; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Lew; Renin; Renin-Angiotensin System; Sex Characteristics; Vascular Endothelial Growth Factor A | 2012 |
Characterization of Angiotensin-(1-7) effects on the cardiovascular system in an experimental model of type-1 diabetes.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Captopril; Cardiovascular System; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Endothelin-1; Hyperglycemia; Kidney; Losartan; Male; NADPH Oxidases; Peptide Fragments; Peptides; Peptidyl-Dipeptidase A; Prostaglandins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Reperfusion Injury | 2012 |
Angiotensin-(1-7) via the mas receptor alleviates the diabetes-induced decrease in GFAP and GAP-43 immunoreactivity with concomitant reduction in the COX-2 in hippocampal formation: an immunohistochemical study.
Topics: Angiotensin I; Animals; Cyclooxygenase 2; Diabetes Mellitus, Experimental; GAP-43 Protein; Glial Fibrillary Acidic Protein; Hippocampus; Male; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled | 2012 |
Metabolism of angiotensin I in the coronary circulation of normal and diabetic rats.
Topics: Angiotensin I; Animals; Chromatography, High Pressure Liquid; Coronary Circulation; Diabetes Mellitus, Experimental; Heart; Male; Peptide Fragments; Perfusion; Rats; Rats, Sprague-Dawley | 2002 |
Angiotensin-(1-7) prevents diabetes-induced cardiovascular dysfunction.
Topics: Angiotensin I; Animals; Blood Pressure; Cardiotonic Agents; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dose-Response Relationship, Drug; Male; Peptide Fragments; Rats; Rats, Wistar; Streptozocin; Vasoconstriction; Vasodilation; Ventricular Dysfunction, Left | 2007 |
Effects of angiotensin 1-7 on the actions of angiotensin II in the renal and mesenteric vasculature of hypertensive and streptozotocin-induced diabetic rats.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Hypertension; Kidney; Male; Nitric Oxide; Peptide Fragments; Prostaglandins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Renal Circulation; Splanchnic Circulation; Streptozocin | 2007 |
Association of somatic and N-domain angiotensin-converting enzymes from Wistar rat tissue with renal dysfunction in diabetes mellitus.
Topics: Angiotensin I; Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Activation; Hypoglycemic Agents; Insulin; Kidney; Male; Molecular Weight; Peptide Fragments; Peptidyl-Dipeptidase A; Protein Structure, Tertiary; Rats; Rats, Wistar; Renin-Angiotensin System | 2007 |
Different responses to angiotensin-(1-7) in young, aged and diabetic rabbit corpus cavernosum.
Topics: Aging; Angiotensin I; Angiotensin II; Animals; Carbachol; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Enzyme Inhibitors; Erectile Dysfunction; Large-Conductance Calcium-Activated Potassium Channels; Male; Muscle Relaxation; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Penis; Peptide Fragments; Peptides; Potassium Channel Blockers; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rabbits; Receptors, G-Protein-Coupled; Vasoconstrictor Agents; Vasodilator Agents | 2007 |
Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Activation; Gene Expression Regulation, Enzymologic; Hyperglycemia; Hypertension, Renal; Male; NADPH Oxidase 4; NADPH Oxidases; Peptide Fragments; Proteinuria; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Vasoconstriction; Vasodilation | 2008 |